about
Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic TargetsNuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS. The role of Akt, IKKα, and DNA damage repair enzymes.ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapyNEMO-binding domain peptide inhibits proliferation of human melanoma cells.In vitro immunization with a recombinant antigen carrying the HIV-1 RT248-262 determinant inserted at different locations results in altered TCRVB region usage.DNA polymorphisms in the 5'-flanking region of the HLA-DQA1 gene.Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholenessUrinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate.In vitroantioxidant, antimicrobial and anti-proliferative activities of purple potato extracts (Solanum tuberosumcv Vitelotte noire) following simulated gastro-intestinal digestionAntigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selectionLong-term culture and T cell receptor analysis of T cell clones isolated from a patient with adenosine deaminase deficiency and type I diabetesModulation of TCR recognition of MHC class II/peptide by processed remote N- and C-terminal epitope extensionsRecognition of HIV-derived B and T cell epitopes displayed on filamentous phagesAdministration of different antigenic forms of altered peptide ligands derived from HIV-1 RTase influences their effects on T helper cell activation
P50
Q26795735-02D6B6CE-F258-4781-9A22-AD4C022B38C3Q34183355-A0278EA1-4CBC-4A6F-B427-0C924C96E690Q34256001-2A4EDAB6-9878-4233-9107-1A59B4AB116EQ39917777-552D502A-0EE2-494C-9142-BF4FB5B372BEQ40922299-A45491A6-28F6-45FE-BE18-6E42F067D247Q41650429-5438D904-2327-4D20-AA9A-1DC5A5914055Q42787883-4FF8657F-7A62-476A-97A6-E994AFA8E0E1Q44567586-5F76BF75-4589-4379-9B53-4753A42E4A3BQ59324120-DE69B926-FA44-4B4C-901E-D112BB06733AQ71740189-DA1B6CFC-2FEB-448E-8E61-AE36A54FB5BDQ72792729-F286E78A-5019-44BF-9E90-E9235B73EE34Q74297441-39E6C0C8-C144-47AA-AC5A-73B22066E9F4Q77297244-81FAF904-E51A-4E1F-A1CA-89FEA3859A4DQ78733922-D70C721C-3AC8-43A6-93DC-8F8C694C415D
P50
description
Italiaans onderzoekster
@nl
researcher, ORCID id # 0000-0002-2437-9276
@en
name
MariaNeve Ombra
@ast
MariaNeve Ombra
@en
MariaNeve Ombra
@es
MariaNeve Ombra
@nl
MariaNeve Ombra
@sl
type
label
MariaNeve Ombra
@ast
MariaNeve Ombra
@en
MariaNeve Ombra
@es
MariaNeve Ombra
@nl
MariaNeve Ombra
@sl
prefLabel
MariaNeve Ombra
@ast
MariaNeve Ombra
@en
MariaNeve Ombra
@es
MariaNeve Ombra
@nl
MariaNeve Ombra
@sl
P106
P1153
6602210815
P21
P27
P31
P496
0000-0002-2437-9276